Our plan is to turn around the Chiron vaccines business, which will require investments in research and development, and manufacturing, to increase quality and capacity, so that we can better meet customer demand and address public health needs. |
We are confident of delivering in 2006 another year of dynamic growth with record sales and earnings. |
We are entering an exciting field with vaccines. Chiron has a fair share of challenges but I believe we can help them in solving those. |
We first want to fix the quality and quantity problems which are at hand. |